Drugs Information: Rituximab
Basic Information
|
||
| ID | DDInter1608 | |
| Drug Type | biotech | |
| Molecular Formula | C6416H9874N1688O1987S44 | |
| Molecular Weight | - | |
| Description | Rituximab is a monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. | |
| ATC Classification | L01XC02 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Rituximab
| Severity level | ID | Name | Mechanism | Detail |
|---|